Positron Emission Tomography Imaging Using Copper Cu 64 TP3805 in Patients With Breast Cancer

NCT02810873 · clinicaltrials.gov ↗

NA

Phase

TERMINATED

Status

19

Enrollment

OTHER

Sponsor class

Stopped Study terminated by PI

Conditions

Breast Carcinoma

Interventions

DEVICE: Positron Emission Mammography
DEVICE: Positron Emission Tomography
RADIATION: Fludeoxyglucose F-18
DRUG: Copper Cu 64 TP3805

Sponsor

Sidney Kimmel Comprehensive Cancer Center at Thomas Jefferson University

Collaborators

[object Object]